This is a compilation of curated news from the LawyersandSettlements.com site regarding the potential adverse affects of using Actos to treat diabetes.
Actos (pioglitazone hydrochloride) is a member of a class of drugs known as thiazolidinediones, which have been linked to liver and cardiovascular issues. Actos side effects include increased risk of congestive heart failure (CHF), increased risk of rare but serious liver problems, an increased risk of fractures, and an increased risk for bladder cancer. The link between Actos and heart failure is strong enough that in 2007 the FDA increased the warnings on the drug concerning congestive heart failure. Actos is used to treat type 2 diabetes.
LawyersandSettlements.com has reported on developments regarding Actos side effects, Actos litigation and FDA monitoring of Actos. The following Actos news articles have been curated from ongoing reporting by LawyersandSettlements.com. The Actos articles shown here are in their full text and are presented in chronological order, dating from August, 2009.
Actos (pioglitazone hydrochloride) is a member of a class of drugs known as thiazolidinediones, which have been linked to liver and cardiovascular issues. Actos side effects include increased risk of congestive heart failure (CHF), increased risk of rare but serious liver problems, an increased risk of fractures, and an increased risk for bladder cancer. The link between Actos and heart failure is strong enough that in 2007 the FDA increased the warnings on the drug concerning congestive heart failure. Actos is used to treat type 2 diabetes.
LawyersandSettlements.com has reported on developments regarding Actos side effects, Actos litigation and FDA monitoring of Actos. The following Actos news articles have been curated from ongoing reporting by LawyersandSettlements.com. The Actos articles shown here are in their full text and are presented in chronological order, dating from August, 2009.
